Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Simultaneous Vinorelbine and Capecitabine in MBC
NCT00629148Phase 2Completed
- Sponsor
- Fudan University
- Start
- Aug 2007
- Primary completion
- Aug 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, capecitabine in breast cancer, sponsored by Fudan University. Started Aug 2007; status: completed.
02
Drugs
vinorelbinecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00629148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629148.